Accreditation: JCI Thailand vs KSPRS/KHIDI Korea
Two separate accreditation frameworks govern the facilities most international patients use in each country — understanding both helps you assess quality signals rather than rely on reputation alone.
Korea’s framework operates through two interlocking bodies. KSPRS (대한성형외과학회, Daehan Seonghyeong Oegwa Haghoe — the Korean Society of Plastic and Reconstructive Surgeons) is South Korea’s official certification board for plastic surgeons.¹ Board certification requires six years of medical school plus a four-year plastic surgery residency and passage of KSPRS examinations.² As of 2024, approximately 2,100 board-certified plastic surgeons are registered with KSPRS.³ Critically, their certification status is publicly searchable — any patient can verify a surgeon’s credentials directly on the KSPRS website before booking.⁴ KSPRS board certification is a legal requirement to perform plastic surgery in licensed Korean facilities; operating without it constitutes an illegal medical act.⁵
Facility-level oversight runs through KOIHA (국제의료기관인증원, Gukje Uiryo Gigwan Injeungwon — Korea’s government-designated international patient safety accreditation body).⁶ KOIHA accreditation requires documented informed consent procedures, emergency response protocols, sterilization standards, qualified anesthesia personnel, and enforceable patient rights policies.⁷ Approximately 350 facilities hold KOIHA accreditation as of 2024.⁸
Thailand’s framework relies primarily on JCI (Joint Commission International) accreditation at its top-tier hospitals. JCI sets comparable standards for patient safety and care quality. Fewer than 20 Korean hospitals hold JCI status,⁹ but Thailand’s major Bangkok hospitals — where most international patients are treated — cluster in this group.
The practical difference: Korea provides a two-layer, publicly verifiable system (surgeon registry + facility accreditation). Thailand’s JCI hospitals provide facility-level assurance but surgeon-level verification requires direct inquiry to the hospital. At the top tier of both markets, safety standards are comparable.
Cost Comparison: Korea vs Thailand
Three factors determine your total spend: the surgical fee, the implant cost (sometimes bundled, sometimes separate), and travel expenses. The table below uses mid-2026 figures; exchange rates used are USD/KRW 1,350 and AUD/USD 0.65. Prices are indicative ranges — always request an itemized quote.
| Tier | Korea fee (USD) | Thailand fee (USD) | Korea all-in (AUD) | Thailand all-in (AUD) |
|---|---|---|---|---|
| Budget clinic | $2,200–3,000 | $1,800–2,600 | $6,500–8,500 | $6,000–8,000 |
| Mid-tier clinic | $3,000–4,500 | $2,800–4,200 | $8,500–11,000 | $8,000–10,500 |
| Top-tier surgeon | $4,500–5,900 | $4,000–5,800 | $11,000–14,500 | $10,500–14,000 |
| All-in from Australia (flights + 10-night stay + surgery) | — | — | $9,000–16,000 | $8,500–15,500 |
| All-in from UK (flights + 10-night stay + surgery) | — | — | £7,500–13,500 | £7,000–13,000 |
The all-in figures for Australia reveal the core dynamic: Korea and Thailand are within AUD $500–1,000 of each other at comparable tiers once flights and accommodation are included. Thailand’s edge is clearest at the budget tier — surgical fees run USD $400–600 lower. At the mid-tier and above, the gap narrows to the point where implant brand preference and surgeon specialization carry more weight than price.
For UK patients, the flight cost differential is larger (Bangkok is approximately 11–12 hours; Seoul is 11–13 hours via common routings), and both are broadly equivalent in travel burden. Neither destination produces a clear cost winner once total spend is calculated honestly.
Quotes from Korean clinics frequently bundle implants, anesthesia, and one follow-up visit. Thai quotes vary — confirm whether anesthesia, post-op garments, and follow-up consultations are included before comparing figures.
Implant Access and Brand Options
Implant brand access is a concrete differentiator between the two markets — and one patients often discover only after booking.
Korea’s aesthetic medicine sector provides broad access to international implant brands. Mentor (Johnson & Johnson) and Allergan (Natrelle, now AbbVie) silicone implants are widely stocked by Seoul clinics alongside Korean-manufactured brands including Hans Biomed (Bellagel) and Sebbin Korea. This means patients can request a specific brand by name and confirm availability before travel — Korean international patient coordinators routinely include implant brand and model in written quotes.
Thailand’s top-tier JCI-accredited hospitals stock international brands including Mentor and Allergan at their main facilities. However, access at mid-tier and smaller Thai clinics is less consistent — some clinics carry only one international brand or substitute with regional alternatives. If you have a strong preference for a specific implant (Allergan Natrelle SmoothSilk/SilkSurface, for example), confirm in writing that the exact model is in stock at your chosen Thai clinic before finalizing travel.
For patients who are indifferent to brand and prioritize surgical technique and surgeon experience, this distinction is less relevant. For revision patients, patients replacing existing implants of a specific brand, or patients whose surgeon has a documented preference for a particular shell type, Korea’s supply breadth is a meaningful practical advantage.
Both markets offer round and anatomical (teardrop) profiles, and both offer a range of projection options. Size and profile selection is handled at the in-person or pre-travel photo consultation in both markets.
Which Destination Suits Which Patient
No single destination is objectively better — the right choice depends on a combination of logistical, clinical, and personal factors.
Korea suits patients who:
- Want to verify surgeon credentials independently before travel (KSPRS public registry makes this straightforward)⁴
- Have a specific implant brand or model preference and want written confirmation of stock
- Are considering a complex case — asymmetry correction, revision, or simultaneous procedures — where Korea’s high specialist case volume is relevant; 1,170,467 foreign patients received medical treatment in Korea in 2024,¹² and plastic surgery and dermatology account for the largest share of that volume¹⁰
- Are traveling from East Asia, Japan, or eastern Australia, where Seoul flight times are comparable to Bangkok
Thailand suits patients who:
- Are traveling from Southeast Asia, South Asia, or the Middle East, where Bangkok is the more convenient hub
- Prefer the environment and infrastructure of Thailand’s established medical tourism ecosystem, including dedicated hospital international patient departments
- Are comfortable navigating JCI hospital accreditation as their primary quality signal
- Are working with a tighter budget and are prepared to research budget-tier options carefully — Thailand’s floor price is marginally lower
Both markets require the same due diligence: confirm the surgeon’s board certification, verify facility accreditation status, request an itemized quote, and confirm anesthesia staffing (a board-certified anesthesiologist, not a nurse anesthetist, for general anesthesia). Neither a Korean flag nor a JCI logo substitutes for patient-level verification.
Is breast augmentation safer in Korea or Thailand?
Safety depends on the specific clinic and surgeon, not the country. Both Korea and Thailand have internationally accredited facilities offering safe breast augmentation. Korea's KSPRS board certification and KHIDI registration provide a verifiable quality signal; Thailand's JCI-accredited hospitals provide an equivalent. The risk increases at budget-tier clinics in both countries — verify board certification, anesthesia staffing, and facility accreditation regardless of destination.
Which country is cheaper for breast augmentation — Korea or Thailand?
Thailand's budget tier is marginally cheaper. At the mid-tier and top-tier level, prices are comparable. For Australian patients, the all-in trip cost is very similar — Thailand flights from eastern Australia are 9–10 hours versus 10–11 hours to Korea. The price difference at comparable quality tiers is not large enough to be the deciding factor; surgeon preference and implant access should drive the decision.
Can I do consultation online before traveling to Korea or Thailand?
Yes — both Korean and Thai medical tourism clinics routinely offer video consultations for international patients. Korean clinics in Gangnam typically have English-speaking international patient coordinators who manage the pre-travel consultation process, send quote breakdowns, and confirm implant brand availability. Request a photo consultation as well as a video call — Korean surgeons often provide detailed written feedback on submitted photos before the in-person consultation.
References
¹ [ksprs-registry-org-identity] Korean Society of Plastic and Reconstructive Surgeons, About page. ² [ksprs-registry-training-requirements] KSPRS, Board certification requirements section. ³ [ksprs-registry-total-certified] KSPRS Annual Report 2024, Membership statistics. ⁴ [ksprs-registry-public-verification] KSPRS, Public registry section. ⁵ [ksprs-registry-legal-requirement] KSPRS and Medical Practices Act reference. ⁶ [kahf-koiha-accreditation-koiha-mandate] KAHF/KOIHA official website, About KOIHA section. ⁷ [kahf-koiha-accreditation-koiha-standards] KOIHA official documentation, Accreditation standards overview. ⁸ [kahf-koiha-accreditation-koiha-count] KOIHA 2024 data, Accredited facility statistics. ⁹ [kahf-koiha-accreditation-jci-count] KOIHA official documentation, International accreditation comparison section. ¹⁰ [khidi-2024-stats-top-specialties] KHIDI 2024, Specialty breakdown section. ¹¹ [khidi-2024-stats-gangnam-concentration] KHIDI 2024, Regional distribution section. ¹² [khidi-2024-stats-total-patients] KHIDI 2024, Executive summary.